Opti-Free: payments to doctors
Payments that named Opti-Free as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Alcon?
Alcon reported the most payments naming Opti-Free. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $21K
- Providers
- 426
- Transactions
- 520
- Average per transaction
- $40
The per-transaction average — $40 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 426 providers the average total is $48, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Alcon | $20,627 | 100.0% |
Other products from Alcon
The company that reported the most payments naming Opti-Free also reports against these.
- Hydrus Microstent$10,650,654
- Precision 1$6,518,719
- TOTAL30$6,495,219
- DAILIES$6,346,146
- Clareon$5,703,387
- DAILIES TOTAL1$5,156,983
- Rocklatan$3,012,468
- Constellation$2,824,936
- AIR OPTIX$2,666,728
- Rhopressa$2,333,542